| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FHLT | Common stock, par value $0.0001 per share | Sale | $6,149 | -614,899 | -86% | $0.0100* | 103,851 | 14 Sep 2021 | See Footnote | F1, F2, F3 |
| holding | FHLT | Common stock, par value $0.0001 per share | 562,781 | 14 Sep 2021 | See Footnote | F4, F5 | |||||
| holding | FHLT | Common stock, par value $0.0001 per share | 11,385 | 14 Sep 2021 | See Footnote | F6, F7 | |||||
| holding | FHLT | Common stock, par value $0.0001 per share | 337,653 | 14 Sep 2021 | See Footnote | F8, F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FHLT | Warrant | Purchase | $713,056 | +713,056 | $1.00* | 713,056 | 14 Sep 2021 | See Footnote | See Footnote | F9, F10 |
| Id | Content |
|---|---|
| F1 | Represents shares transferred by MB Equity, LLC to anchor investors in connection with the Issuer's initial public offering at the same price per share as MB Equity, LLC initially paid for such shares. |
| F2 | Includes up to 13,546 shares subject to forfeiture by MB Equity, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full. |
| F3 | The shares are held directly by MB Equity, LLC. The Reporting Person disclaims beneficial ownership of the securities held by MB Equity, LLC other than the reported securities except to the extent of his pecuniary interest therein. |
| F4 | Includes up to 73,406 shares subject to forfeiture by BEA Holdings, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full. |
| F5 | The shares are held directly by BEA Holdings, LLC, of which the Reporting Person is the sole manager. |
| F6 | Includes up to 1,485 shares subject to forfeiture by hc1.com, Inc. if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full. |
| F7 | The shares are held directly by hc1.com, Inc., of which the Reporting Person is the Chief Executive Officer and Chairman. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by hc1.com, Inc. other than the reported securities except to the extent of his pecuniary interest therein. |
| F8 | Includes up to 44,042 shares subject to forfeiture by Future Health ESG Associates 1, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full. |
| F9 | The securities are held directly by Future Health ESG Associates 1, LLC, of which the Reporting Person is a manager, and indirectly by b2 Holdings, LLC, of which the Reporting Person is the manager, BEA Holdings, LLC, and three individual retirement accounts in the names of two of the Reporting Person's daughters and the Reporting Person's son, respectively. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by Future Health ESG Associates 1, LLC other than the reported securities except to the extent of his pecuniary interest therein. |
| F10 | Each warrant will become exercisable 30 days after the completion of the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment in the event of certain capital-raising or reorganization transactions. |